Shattuck Labs Newsroom

Express News | Shattuck Labs Inc : Citigroup Cuts Target Price to $10 From $11

ReutersMay 23 05:59 ET

TD Cowen Remains a Buy on Shattuck Labs (STTK)

TipRanksMay 15 07:16 ET

Promising Clinical Trial Results Support a Buy Rating for Shattuck Labs

TipRanksMay 15 06:09 ET

Express News | Shattuck Labs To Present Additional Data From Phase 1B Dose Expansion Trial Of SL-172154 Trial At EHA 2024 Congress Jun. 14

BenzingaMay 14 16:25 ET

Express News | Shattuck Labs Inc - Sl-172154 Continued to Demonstrate an Acceptable Safety Profile in Combination With Aza

ReutersMay 14 16:15 ET

Shattuck Labs to Present Additional Data From the Phase 1B Dose Expansion Clinical Trial of SL-172154 With Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 Mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK) today announced the presentation of additional data from the Phase 1B dose expansion clinical trial of SL-172154 with AZA in frontline HR-MDS and TP53m AML patients.

GlobeNewswireMay 14 16:15 ET

Buy Rating Affirmed: Shattuck Labs' Promising Clinical Developments in HR-MDS and AML Treatment

TipRanksMay 14 12:15 ET

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Acrivon Therapeutics, Inc. (ACRV)

TipRanksMay 14 12:10 ET

Shattuck Labs First Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceMay 4 08:01 ET

Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results

Yahoo FinanceMay 4 05:31 ET

Buy Rating Affirmed for Shattuck Labs Ahead of Key Clinical Trial Updates on SL-172154

TipRanksMay 2 14:35 ET

Express News | HC Wainwright & Co. Reiterates Buy on Shattuck Labs, Maintains $28 Price Target

BenzingaMay 2 13:15 ET

Shattuck Labs: Buy Rating Affirmed on Strong Q1 Financials and Promising Clinical Milestones

TipRanksMay 2 11:35 ET

Express News | Shattuck Labs Cash And Cash Equivalents And Investments Of $114.6M For The Quarter Ended March 31, 2024, Will Be Sufficient To Fund Its Operations Into 2026

BenzingaMay 2 08:14 ET

Express News | Shattuck Labs: Cash, Equivalents, Investments to Be Sufficient to Fund Ops Into 2026, Beyond Results From Phase 1 Clinical Trials of Sl-172154

ReutersMay 2 07:08 ET

Shattuck Labs 1Q Loss/Shr 37c >STTK

Shattuck Labs 1Q Loss/Shr 37c >STTK

Dow JonesMay 2 07:05 ET

Express News | Shattuck Labs Q1 Income From Operations USD -20.044 Million

ReutersMay 2 07:05 ET

Express News | Shattuck Labs Q1 Basic EPS USD -0.37

ReutersMay 2 07:05 ET

Express News | Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

ReutersMay 2 07:05 ET

Express News | Shattuck Labs Q1 Net Income USD -18.504 Million

ReutersMay 2 07:05 ET